Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Clinicians map pain by dividing the body into four quadrants, left and right, above and below the waist, then check whether the axial skeleton (neck, chest, mid back, or low back) is also involved. True generalized pain typically requires symptoms in all four quadrants plus axial pain lasting three months or longer, which separates genuinely widespread conditions like fibromyalgia from regional or referred pain that only appears to be everywhere. Scoring systems, tender point counts, fatigue, and sleep quality all shift how a pain map is interpreted, and there are several important factors to consider, so see below to understand more.
Because a pain map is only meaningful alongside your full symptom picture, it helps to organize what you are feeling before your next appointment. A free, instant, online symptom check takes just a few minutes, helps you see which patterns your symptoms fit, and gives you clearer language and next steps to discuss with a clinician.
Last reviewed for medical accuracy: 08/18/2026
Chronic widespread pain in all four quadrants can disrupt daily life, making simple tasks feel overwhelming. Clinicians use quadrant pain maps to distinguish true generalized pain from localized discomfort. By combining patient history, physical exams, and validated tools, they aim to create an accurate picture of your pain pattern—helping tailor treatments that address the root causes.
Quadrant pain maps divide the body into four regions:
A map shows which areas hurt, how intense the pain is, and whether it crosses the midline. True generalized pain means you have discomfort:
When pain appears in all four quadrants, clinicians consider it chronic widespread pain—a feature of conditions like fibromyalgia, central sensitization syndromes, and some autoimmune disorders.
Accurate Diagnosis
Pain in a single joint or muscle group often points to injury or overuse. But chronic widespread pain in all four quadrants suggests a systemic issue—requiring a different approach.
Treatment Guidance
Knowing the distribution helps doctors decide which therapies to prioritize: physical therapy, medications, behavioral strategies, or a combination.
Tracking Progress
Repeating the map at intervals shows whether treatments are reducing pain regions and intensity.
Clinicians often supplement maps with validated questionnaires:
Using WPI and SSS together aligns with the American College of Rheumatology (ACR) criteria for fibromyalgia—but the approach also applies to other chronic widespread pain conditions.
To qualify as generalized pain, you must have:
When all five areas are involved for at least three months, clinicians consider chronic widespread pain present. The criteria help distinguish it from regional pain syndromes or single-joint issues.
Not all four-quadrant pain is fibromyalgia. Doctors rule out:
By ruling out or confirming these conditions, clinicians ensure you get the right diagnosis and treatment.
One key concept in chronic widespread pain is central sensitization—when your nervous system becomes more sensitive to pain signals. Features include:
Clinicians assess for signs of central sensitization through careful questioning and pain mapping. Recognizing this helps shift treatment toward therapies that modulate the nervous system, such as:
Once true generalized pain is established, a multimodal approach often works best:
Regular follow-up pain maps let you and your clinician see:
These insights guide adjustments in medication dosage, therapy intensity, or introducing new modalities.
Curious where your pain fits? Consider doing a free, online symptom check using the doctor-approved Ubie Symptom Checker. It can help you:
Chronic widespread pain in all four quadrants is complex, but you don’t have to face it alone. Always consult a healthcare professional if you experience:
A doctor can order tests, confirm diagnoses, and design a treatment plan tailored to you.
Talking openly about your pain map helps your care team understand your unique experience. By combining your insights with clinical expertise, you can work toward better pain control, improved function, and a higher quality of life. Remember: no question is too small—your health matters. If anything feels serious or life-threatening, speak to a doctor right away.
(References)
* Patkar AA, Bilal L, Masand PS. Management of fibromyalgia. Curr Psychiatry Rep. 2003 Jul;5(3):218-24. doi: 10.1007/s11920-003-0046-9. PMID: 12773276.
* Chakrabarty S, Zoorob R. Fibromyalgia. Am Fam Physician. 2007 Jul 15;76(2):247-54. PMID: 17695569.
* Ablin JN, Buskila D, Clauw DJ. Biomarkers in fibromyalgia. Curr Pain Headache Rep. 2009 Oct;13(5):343-9. doi: 10.1007/s11916-009-0056-3. PMID: 19728959.
* Atzeni F, Sallì S, Benucci M, Di Franco M, Alciati A, Sarzi-Puttini P. Fibromyalgia and arthritides. Reumatismo. 2012 Sep 28;64(4):286-92. doi: 10.4081/reumatismo.2012.286. Epub 2012 Sep 28. PMID: 23024973.
* Fayaz A, Croft P, Langford RM, Donaldson LJ, Jones GT. Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. BMJ Open. 2016 Jun 20;6(6):e010364. doi: 10.1136/bmjopen-2015-010364. Epub 2016 Jun 20. PMID: 27324708; PMCID: PMC4932255.
* Dougados M, Perrot S. Fibromyalgia and central sensitization in chronic inflammatory joint diseases. Joint Bone Spine. 2017 Oct;84(5):511-513. doi: 10.1016/j.jbspin.2017.03.001. Epub 2017 Mar 12. PMID: 28300697.
* Neumeister MW, Neumeister EL. Fibromyalgia. Clin Plast Surg. 2020 Apr;47(2):203-213. doi: 10.1016/j.cps.2019.12.007. Epub 2020 Feb 6. PMID: 32115047.
* Cabezas-Yagüe E, Martínez-Pozas O, Gozalo-Pascual R, Muñoz Blanco E, Lopez Paños R, Jiménez-Ortega L, Cuenca-Zaldívar JN, Sánchez Romero EA. Comparative effectiveness of Maitland Spinal Mobilization versus myofascial techniques on pain and symptom severity in women with Fibromyalgia syndrome: A quasi-randomized clinical trial with 3-month follow up. Musculoskelet Sci Pract. 2024 Oct;73:103160. doi: 10.1016/j.msksp.2024.103160. Epub 2024 Aug 8. PMID: 39182326.
* Lederman S, Arnold LM, Vaughn B, Engels JM, Kelley M, Sullivan GM. Pain relief by targeting nonrestorative sleep in fibromyalgia: a phase 3 randomized trial of bedtime sublingual cyclobenzaprine. Pain Med. 2026 Jan 1;27(1):86-94. doi: 10.1093/pm/pnaf089. PMID: 40627411; PMCID: PMC12773742.
* Kelleher EM, Lange F, Wanigasekera V, Rathod-Mistry T, Nichols T, Seymour B, Tracey I, Segerdahl AR, Irani A. Brain signatures of nociplastic pain: Fibromyalgia Index and descending modulation at population level. Brain. 2026 Apr 7;149(4):1365-1380. doi: 10.1093/brain/awaf307. PMID: 40819274; PMCID: PMC7618718.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.